Pharmaceutical companies want to quickly manufacture a vaccine against covid-19, with human testing and launch in the market as soon as possible. In a debate article, Jessica Nihlén Fahlquist at CRB warns of the risk of losing the larger risk perspective: “Tests on people and a potential premature mass vaccination entail risks. It is easy to forget about similar situations in the past,” she writes.
It may take time for side effects to appear. Unfortunately, it therefore also takes time to develop new safe vaccines. We need to develop a vaccine, but even with new vaccines, caution is needed.
The article is in Swedish. If you want to Google translate: Proceed carefully with vaccine against covid-19
Written by…
Pär Segerdahl, Associate Professor at the Centre for Research Ethics & Bioethics and editor of the Ethics Blog.
We have a clinical perspective
Recent Comments